Literature DB >> 11182037

Clinicopathologic study on cholangiolocellular carcinoma.

K Shiota1, J Taguchi, O Nakashima, M Nakashima, M Kojiro.   

Abstract

We clinicopathologically studied 6 resected cases of cholangiolocarcinoma (CLC) including 2 referred cases from other hospitals. The frequency of CLC was 0.56% of the 708 consecutively resected cases of primary liver cancer and the mean age of CLC cases was 66 years. Three of the 6 cases (50%) were hepatitis C virus antibody (HCVab) positive, one (17%) was hepatitis B virus surface antigen (HBsAg) positive, and 2 (33%) were negative to both HCVAb and HBsAg. Serum levels of alpha-fetoprotein were slightly elavated only in 1 case. Clinically, 4 cases were diagnosed as hepatocellular carcinoma (HCC) and 2 cases as cholangiocellular carcinoma (CCC). Grossly, CLCs were whitish in color and solid, not encapsulated, and resembled CCC. Histologically, the tumor cells had eosinophilic cytoplasm with ovoid nuclei, and mild atypia. The tumor proliferated in an anastomosing pattern of Hering's canal-like small glands with an abundant fibrous stroma. Four of the 6 tumors (83%) consisted of only CLC and other 2 tumors contained CCC-like area and HCC-like area in a part of the nodules, respectively. Immunohistochemically, all tumors were positive to cytokeratin (CK) 7. CK8 were also positive in all of 6 cases. These results revealed that CLC had the clinical features resembling HCC but the morphologic features resembling CCC. It is suggested that CLC cells might be derived from Hering's canal or stem cells which have the intermediate features between hepatocytes and bile duct epithelium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11182037

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  23 in total

1.  Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA.

Authors:  Xing-Lei Qin; Zhuo-Ren Wang; Jing-Sen Shi; Min Lu; Lin Wang; Quan-Ru He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

2.  A case of a large cholangiolocellular carcinoma.

Authors:  Moe Kadono; Kiminori Kimura; Jun Imamura; Shunichi Saeki; Masanao Kurata; Goro Honda; Koji Tsuruta; Shinichiro Horiguchi; Seishu Hayashi
Journal:  Clin J Gastroenterol       Date:  2011-08-07

Review 3.  Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.

Authors:  Elizabeth M Brunt; Valerie Paradis; Christine Sempoux; Neil D Theise
Journal:  Hepat Oncol       Date:  2015-07-28

Review 4.  Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis.

Authors:  Shun-ichi Ariizumi; Masakazu Yamamoto
Journal:  Surg Today       Date:  2014-09-25       Impact factor: 2.549

5.  S-1 monotherapy in a patient with cholangiolocellular carcinoma: A case report.

Authors:  Takashi Yamaguchi; Toshihito Seki; Ryosuke Inokuchi; Rinako Kawamura; Miki Murata; Koichi Matsuzaki; Osamu Nakashima; Tsutomu Kumabe; Kazuichi Okazaki
Journal:  Mol Clin Oncol       Date:  2016-10-11

6.  A case of cholangiolocellular carcinoma asynchronously developing 3 years after the resection of hepatocellular carcinoma.

Authors:  Masaya Iwamuro; Hirofumi Kawamoto; Tsuneyoshi Ogawa; Takehiro Tanaka; Takahito Yagi; Kazuhide Yamamoto
Journal:  Clin J Gastroenterol       Date:  2009-02-11

7.  Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma.

Authors:  Yusuke Ono; Yutaro Hiratsuka; Masaki Murata; Akira Takasawa; Rieko Fukuda; Masanori Nojima; Satoshi Tanaka; Makoto Osanai; Koichi Hirata; Norimasa Sawada
Journal:  Virchows Arch       Date:  2016-07-21       Impact factor: 4.064

Review 8.  Cholangiolocellular carcinoma with rapid progression initially showing abnormally elevated serum alfa-fetoprotein.

Authors:  Tomoaki Yoh; Tatsushi Kato; Yoshiaki Hirohata; Yuya Nakamura; Hiroyuki Nakayama; Ryuji Okamura
Journal:  Clin J Gastroenterol       Date:  2016-06-30

9.  Giant Cholangiolocellular Carcinoma With Early Recurrence That Was Difficult to Distinguish From Cholangiocellular Carcinoma: Report of a Case.

Authors:  Norihiro Ishii; Hideki Suzuki; Mariko Tsukagoshi; Akira Watanabe; Norio Kubo; Kenichiro Araki; Satoshi Wada; Hiroyuki Kuwano
Journal:  Int Surg       Date:  2015-06

10.  High expression of cancer stem cell markers in cholangiolocellular carcinoma.

Authors:  Shuichi Iwahashi; Tohru Utsunomiya; Mitsuo Shimada; Yu Saito; Yuji Morine; Satoru Imura; Tetsuya Ikemoto; Hiroki Mori; Jun Hanaoka; Yoshimi Bando
Journal:  Surg Today       Date:  2012-11-29       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.